Tue12012020

Last updateThu, 26 Nov 2020 5pm

Back You are here: Inicio Biology & biomedicine

A new therapeutic target for the treatment of nonalcoholic fatty liver disease

Scientists of the IIBB-CSIC discover a new role for sphingomyelin synthase 1 enzyme in nonalcoholic steatohepatitis, an advanced stage of fatty liver disease. The work identifies SMS1 enzyme as a possible new therapeutic target.

Read more ...

A combination of peptides and antibiotics may result in a more effective treatment for leishmaniasis

A combination of peptides and antibiotics could be a key for fighting Leishmania parasites and avoiding the toxicity caused by current drugs to people and animals. CSIC scientists have participated in this research that opens the door to new and more effective treatments against leishmaniasis.

Read more ...

Test for the diagnosis of P. aeruginosa infections by detecting its communication molecules

The CSIC has developed an immunochemical technique for the diagnosis of Pseudomonas aeruginosa infections. It detects the main signalling molecules that the bacteria use to communicate (Quorum Sensing). The test is very specific and has high sensitivity, as well as a high capacity for sample processing, which ensures diagnostic efficiency. It can also be easily implemented on point-of-care (PoC) devices.

Read more ...

Immune stimulation can help increase aquaculture production by altering epigenetic modifications

Scientists at the Institut de Ciències del Mar of the CSIC have demonstrated that some stimulations of the immune system during the early stages of fish development can trigger epigenetic modifications that lead to changes in the sexual phenotype. This could have important implications for aquaculture production in those species where the female has the greatest growth, since the more females there are, the higher the production.

Read more ...

New method for a controlled release of ophthalmic drugs

Scientists at the CSIC and the University of Zaragoza have developed a new formulation to achieve a controlled and sustained release of different drugs inside the eyeball. Industrial partners from the ophthalmic or pharmaceutical industry are being sought to collaborate through a patent licence agreement.

Read more ...